The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AC IMMUNE SA | SHS | H00263105 | 47,916 | 9,818,758 | SH | DFND | 1 | 0 | 9,818,758 | 0 | |
ALX ONCOLOGY HLDGS INC | COM | 00166B105 | 24,113 | 638,928 | SH | DFND | 1 | 0 | 638,928 | 0 | |
AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 4,631 | 1,100,000 | SH | DFND | 1 | 0 | 1,100,000 | 0 | |
ANAPTYSBIO INC | COM | 032724106 | 18,104 | 1,227,405 | SH | DFND | 1 | 0 | 1,227,405 | 0 | |
ARCUS BIOSCIENCES INC | COM | 03969F109 | 44,516 | 2,597,222 | SH | DFND | 1 | 0 | 2,597,222 | 0 | |
ARGENX SE | SPONSORED ADR | 04016X101 | 44,523 | 169,600 | SH | DFND | 1 | 0 | 169,600 | 0 | |
BCTG ACQUISITION CORP | COM | 05492W103 | 8,288 | 800,000 | SH | DFND | 1 | 0 | 800,000 | 0 | |
BIOLINERX LTD | SPONSORED ADS | 09071M205 | 2,766 | 1,686,375 | SH | DFND | 1 | 0 | 1,686,375 | 0 | |
CALITHERA BIOSCIENCES INC | COM | 13089P101 | 15,820 | 4,585,638 | SH | DFND | 1 | 0 | 4,585,638 | 0 | |
CALLIDITAS THERAPEUTICS AB | SPONSORED ADS | 13124Q106 | 18,000 | 750,000 | SH | DFND | 1 | 0 | 750,000 | 0 | |
CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 45,481 | 3,066,797 | SH | DFND | 1 | 0 | 3,066,797 | 0 | |
CIDARA THERAPEUTICS INC | COM | 171757107 | 10,735 | 3,766,704 | SH | DFND | 1 | 0 | 3,766,704 | 0 | |
CONTRAFECT CORP | COM NEW | 212326300 | 8,448 | 1,600,000 | SH | DFND | 1 | 0 | 1,600,000 | 0 | |
CORVUS PHARMACEUTICALS INC | COM | 221015100 | 6,992 | 1,743,712 | SH | DFND | 1 | 0 | 1,743,712 | 0 | |
CTI BIOPHARMA CORP | COM | 12648L601 | 14,899 | 6,929,690 | SH | DFND | 1 | 0 | 6,929,690 | 0 | |
CURIS INC | COM NEW | 231269200 | 4,271 | 3,650,000 | SH | DFND | 1 | 0 | 3,650,000 | 0 | |
CYTOKINETICS INC | COM NEW | 23282W605 | 71,944 | 3,323,051 | SH | DFND | 1 | 0 | 3,323,051 | 0 | |
CYTOMX THERAPEUTICS INC | COM | 23284F105 | 23,672 | 3,559,722 | SH | DFND | 1 | 0 | 3,559,722 | 0 | |
ERYTECH PHARMA | SPONSORED ADR | 29604W108 | 3,906 | 625,000 | SH | DFND | 1 | 0 | 625,000 | 0 | |
ESSA PHARMA INC | COM NEW | 29668H708 | 20,739 | 3,005,589 | SH | DFND | 1 | 0 | 3,005,589 | 0 | |
EVELO BIOSCIENCES INC | COM | 299734103 | 6,851 | 1,300,000 | SH | DFND | 1 | 0 | 1,300,000 | 0 | |
EXELIXIS INC | COM | 30161Q104 | 374 | 15,300 | SH | DFND | 1 | 0 | 15,300 | 0 | |
FIVE PRIME THERAPEUTICS INC | COM | 33830X104 | 37,644 | 8,009,353 | SH | DFND | 1 | 0 | 8,009,353 | 0 | |
FORTE BIOSCIENCES INC | COM | 34962G109 | 37,719 | 777,553 | SH | DFND | 1 | 0 | 777,553 | 0 | |
FORWARD PHARMA A/S | SPONSORD ADS NEW | 34986J204 | 4,033 | 647,299 | SH | DFND | 1 | 0 | 647,299 | 0 | |
GALMED PHARMACEUTICALS LTD | SHS | M47238106 | 6,353 | 1,799,694 | SH | DFND | 1 | 0 | 1,799,694 | 0 | |
GAMIDA CELL LTD | SHS | M47364100 | 8,896 | 2,143,667 | SH | DFND | 1 | 0 | 2,143,667 | 0 | |
GENOCEA BIOSCIENCES INC | COM NEW | 372427401 | 9,188 | 4,012,404 | SH | DFND | 1 | 0 | 4,012,404 | 0 | |
GLYCOMIMETICS INC | COM | 38000Q102 | 22,240 | 7,244,262 | SH | DFND | 1 | 0 | 7,244,262 | 0 | |
IDEAYA BIOSCIENCES INC | COM | 45166A102 | 40,528 | 3,226,769 | SH | DFND | 1 | 0 | 3,226,769 | 0 | |
IMMUNOVANT INC | COM | 45258J102 | 42,173 | 1,198,427 | SH | DFND | 1 | 0 | 1,198,427 | 0 | |
INFINITY PHARMACEUTICALS INC | COM | 45665G303 | 20,390 | 17,426,968 | SH | DFND | 1 | 0 | 17,426,968 | 0 | |
IONIS PHARMACEUTICALS INC | COM | 462222100 | 34,878 | 735,055 | SH | DFND | 1 | 0 | 735,055 | 0 | |
KURA ONCOLOGY INC | COM | 50127T109 | 45,626 | 1,489,112 | SH | DFND | 1 | 0 | 1,489,112 | 0 | |
KYMERA THERAPEUTICS INC | COM | 501575104 | 84,997 | 2,630,658 | SH | DFND | 1 | 0 | 2,630,658 | 0 | |
MEI PHARMA INC | COM NEW | 55279B202 | 12,730 | 4,080,162 | SH | DFND | 1 | 0 | 4,080,162 | 0 | |
MERUS N V | COM | N5749R100 | 67,747 | 5,645,571 | SH | DFND | 1 | 0 | 5,645,571 | 0 | |
MOLECULAR TEMPLATES INC | COM | 608550109 | 23,468 | 2,149,057 | SH | DFND | 1 | 0 | 2,149,057 | 0 | |
NOVUS THERAPEUTICS INC | COM | 67011N105 | 3,340 | 3,515,873 | SH | DFND | 1 | 0 | 3,515,873 | 0 | |
OVID THERAPEUTICS INC | COM | 690469101 | 20,791 | 3,622,051 | SH | DFND | 1 | 0 | 3,622,051 | 0 | |
PANACEA ACQUISITION CORP | UNIT 99/99/9999 | 698102209 | 9,600 | 800,000 | SH | DFND | 1 | 0 | 800,000 | 0 | |
PHATHOM PHARMACEUTICALS INC | COM | 71722W107 | 11,811 | 322,098 | SH | DFND | 1 | 0 | 322,098 | 0 | |
PIERIS PHARMACEUTICALS INC | COM | 720795103 | 11,374 | 5,494,582 | SH | DFND | 1 | 0 | 5,494,582 | 0 | |
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 46,378 | 2,372,288 | SH | DFND | 1 | 0 | 2,372,288 | 0 | |
REGULUS THERAPEUTICS INC | COM NEW | 75915K200 | 1,654 | 3,217,480 | SH | DFND | 1 | 0 | 3,217,480 | 0 | |
RELAY THERAPEUTICS INC | COM | 75943R102 | 143,885 | 3,378,380 | SH | DFND | 1 | 0 | 3,378,380 | 0 | |
REPARE THERAPEUTICS INC | COM | 760273102 | 94,302 | 3,064,734 | SH | DFND | 1 | 0 | 3,064,734 | 0 | |
REPLIMUNE GROUP INC | COM | 76029N106 | 38,946 | 1,691,834 | SH | DFND | 1 | 0 | 1,691,834 | 0 | |
REVOLUTION MEDICINES INC | COM | 76155X100 | 73,117 | 2,101,049 | SH | DFND | 1 | 0 | 2,101,049 | 0 | |
SELECTA BIOSCIENCES INC | COM | 816212104 | 20,980 | 8,459,547 | SH | DFND | 1 | 0 | 8,459,547 | 0 | |
SPERO THERAPEUTICS INC | COM | 84833T103 | 15,003 | 1,344,334 | SH | DFND | 1 | 0 | 1,344,334 | 0 | |
SPRING BK PHARMACEUTICALS IN | COM | 849431101 | 1,261 | 941,171 | SH | DFND | 1 | 0 | 941,171 | 0 | |
SPRINGWORKS THERAPEUTICS INC | COM | 85205L107 | 97,914 | 2,053,991 | SH | DFND | 1 | 0 | 2,053,991 | 0 | |
SUNESIS PHARMACEUTICALS INC | COM NEW | 867328874 | 2,159 | 1,727,308 | SH | DFND | 1 | 0 | 1,727,308 | 0 | |
SUTRO BIOPHARMA INC | COM | 869367102 | 31,026 | 3,087,195 | SH | DFND | 1 | 0 | 3,087,195 | 0 | |
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 36,467 | 2,470,678 | SH | DFND | 1 | 0 | 2,470,678 | 0 | |
THERAPEUTICS ACQUISITION COR | COM CL A | 88339T103 | 14,380 | 1,000,000 | SH | DFND | 1 | 0 | 1,000,000 | 0 | |
VERASTEM INC | COM | 92337C104 | 13,005 | 10,747,994 | SH | DFND | 1 | 0 | 10,747,994 | 0 | |
X4 PHARMACEUTICALS INC | COM | 98420X103 | 5,368 | 792,892 | SH | DFND | 1 | 0 | 792,892 | 0 | |
XENCOR INC | COM | 98401F105 | 80,222 | 2,068,098 | SH | DFND | 1 | 0 | 2,068,098 | 0 | |
XENON PHARMACEUTICALS INC | COM | 98420N105 | 38,738 | 3,499,346 | SH | DFND | 1 | 0 | 3,499,346 | 0 | |
XOMA CORP DEL | COM NEW | 98419J206 | 78,793 | 4,182,243 | SH | DFND | 1 | 0 | 4,182,243 | 0 |